Background
==========

High-throughput expression profiling is a major tool for functional annotation of sequenced genomes. SAGEmap \[[@B1]\] and NCI60 cDNA microarray \[[@B2]\] datasets have been incorporated into the Ensembl and UCSC human genome browsers. Large-scale expression data have also been used to construct a transcriptional profile of adult skeletal muscle \[[@B3]\]; to identify genes preferentially expressed in prostate \[[@B4]\], granulocytes \[[@B5]\] and thyroid \[[@B6]\]; to discover markers of pathological states such as cancer \[[@B7]\], and for whole genome structure analysis such as identification of clusters of similarly expressed genes \[[@B8],[@B9]\].

Numerous public databases have been created to store large-scale expression data. These databases are, however, heterogeneous in format, sample annotation, and statistical post-processing of experimental results. Furthermore, the different databases store data from different experimental technologies. A cross-platform comparison between cDNA and oligonucleotide microarrays has demonstrated that data generated by different platforms may have poor correlation \[[@B10]\]. We investigated whether three public gene expression databases: the Gene Expression Atlas published by Su et al. \[[@B11]\], SAGEmap \[[@B1]\] and TissueInfo \[[@B12]\] (representing respectively oligonucleotide microarray, Serial Analysis of Gene Expression -- SAGE, and Expressed Sequence Tags -- ESTs) are internally consistent and complementary when used to compare expression profiles of human genes within six normal tissue categories, which were represented in the three databases.

The scope of this study is integration of expression data and meta-analysis of datasets. Our aim is to evaluate the congruence of publicly available expression datasets. It was not our intention to provide a technical benchmarking of different expression platforms, because such a benchmarking exercise would require controlled microarray, SAGE and EST experiments starting with identical RNA samples derived from the same tissue specimen, and would be beyond the resources of most laboratories.

Results and discussion
======================

Preferential Expression Measure
-------------------------------

We devised a Preferential Expression Measure (PEM) to score differential expression of genes in tissues. PEM describes the expression of a gene in a given tissue in relation to its expression in all tissues. Therefore, PEM controls for the fact that some genes are highly expressed across many tissues (housekeeping genes), and has the virtue of reporting a negative value for under-expressed genes, and a positive value for over-expressed genes. Large positive PEM scores for a gene in a particular tissue indicate that the gene is unusually highly expressed in that tissue, relative to its expression in other tissues. Large negative PEM scores indicate repression of a gene in a tissue.

For SAGEmap and TissueInfo we define PEM as *log*~10~(*o/e*), where *o*is the observed SAGE or EST tag count for a gene in a given tissue, and *e*the expected tag count under the null hypothesis of uniform expression in all tissues. *e*is calculated as (*G \* N/T*) where *G*is the total number of tags ascribed to the gene, *N*is the total number of tags for the tissue, and *T*is the total number of tags in the dataset.

For example, carbonic anhydrase XI (UniGene cluster Hs.22777) is linked to a SAGE tag GTCGCTGAGA. This tag occurs 132 times in all normal tissue SAGEmap libraries. The total number of SAGE tags in the normal brain tissue category is 326,481, and the total number of tags in all normal tissue categories is 1,077,231. Therefore, if the distribution of this tag was uniform across all libraries, it would be expected to occur \~40 times (132 \* 326,481/1,077,231) in brain libraries (expected count). The actual count in brain libraries is 124 (observed count) bringing the PEM value for this tag in brain to *log*~10~(*o/e*) = *log*~10~(132/40) = 0.49.

For microarray experiments, where the raw data is a continuous variable (a relative intensity of a gene-specific fluorescent signal) as opposed to a tag count, we defined PEM as *log*~10~(*S/A*), where *S*is the specific tissue signal for a gene and *A*is the arithmetic mean signal for the gene across all tissues.

Reproducibility and internal consistency
----------------------------------------

A major concern with all types of high-throughput expression data is reproducibility and internal consistency. To investigate this, for each of the three databases, we compared replicate experiments (where available) or equivalent tissues and measured the Pearson correlation coefficient for relative fluorescent signal intensity values assigned to the same probe in a pair of experiments. Gene Expression Atlas oligonucleotide microarray data had good correlation between repeat hybridizations of the same RNA sample (mean *r*^2^= 0.94 ± 0.04; N = 45 pairwise comparisons) and, as expected, slightly lower values for repeat hybridizations of different RNA preparations from the same tissue type (mean *r*^2^= 0.87 ± 0.06; N = 17 pairwise comparisons).

Internal correlations for SAGEmap and TissueInfo were lower. Counts of identical tags were correlated in pairwise SAGEmap library comparisons yielding mean *r*^2^values of 0.51 ± 0.25, N = 15 for brain; 0.26 ± 0.08, N = 6 for prostate; 0.89, N = 2 for vascular endothelium; 0.27, N = 2 for ovary; 0.83, N = 2 for kidney; and 0.97, N = 2 for pancreas.

For TissueInfo, we included tumour tissues to maximize the size of datasets and, therefore, minimize the sampling error. Counts of EST tags linked to the same UniGene cluster in pools of libraries were correlated. Comparison of brain TissueInfo libraries comprising 154,214 EST tags from normal tissue and 111,317 from tumour tissue, revealed an *r*^2^of only 0.27.

Correlations among tissue profiles from Gene Expression Atlas, SAGEmap and TissueInfo
-------------------------------------------------------------------------------------

To compare different databases we grouped libraries into higher-level tissue categories, and calculated Pearson correlation coefficients for PEM scores for categories that were represented in all three databases. Tumour tissue libraries were not used in any of the interdatabase comparisons. UniGene was used as the common gene index to link entries from the three databases. There were six tissues available for comparison (Table [1](#T1){ref-type="table"}). Significant positive correlations were found for brain, prostate and vascular endothelium (Figure [1](#F1){ref-type="fig"}) but not for ovary, kidney, and pancreas.

###### 

*r*^2^values for Pearson correlations between PEM scores computed from Gene Expression Atlas (GEA), SAGEmap and TissueInfo expression profiles for six human tissue categories, for which data were available in the three databases.

                         Tissue     TissueInfo vs. SAGEmap   GEA vs. SAGEmap   GEA vs. TissueInfo                                                                        
  ---------------------- ---------- ------------------------ ----------------- -------------------- ---------- -------- -------- ---------- ---------- -------- -------- ----------
                         Genes^a^   *r*^2^                   P^b^              Signs^c^             Genes^a^   *r*^2^   P^b^     Signs^c^   Genes^a^   *r*^2^   P^b^     Signs^c^
                                                                                                                                                                         
  Brain                  346        0.59                     \<0.01            92%                  479        0.49     \<0.01   84%        1431       0.43     \<0.01   77%
  Prostate               58         0.36                     \<0.01            76%                  237        0.09     \<0.01   59%        266        0.19     \<0.01   63%
  Vascular endothelium   13         0.29                     0.6               92%                  150        0.37     \<0.01   73%        23         0.05     0.29     39%
  Ovary                  10         0.11                     0.35              30%                  175        0.03     0.2      49%        36         0.03     0.28     69%
  Kidney                 103        0.01                     0.36              34%                  140        0.00     0.78     50%        508        0.11     \<0.01   55%
  Pancreas               21         0.02                     0.55              62%                  141        0.00     0.59     48%        82         0.02     0.19     55%

^a^Number of genes compared. SAGEmap and TissueInfo data were only used for genes whose PEM scores were significant by χ^2^test (P = 0.05), and only tags that could be mapped unambiguously to UniGene were used. ^b^Two-tailed significance values for Pearson correlation coefficients. ^c^Percentage of genes whose PEM scores have the same sign for the two methods being compared.

![**Correlations between the three databases**Correlations between Gene Expression Atlas (GEA), SAGEmap, and TissueInfo preferential expression measures (PEM) for brain, prostate and vascular endothelium. Trend lines for linear regression and the corresponding *r*^2^values are shown for each pairwise comparison.](1471-2164-4-31-1){#F1}

Because of sampling error, the total number of sequenced tags is a key determinant of reliability of SAGE and EST expression profiles. In our analysis, brain is the tissue category with the highest number of both SAGE and EST tags (Table [2](#T2){ref-type="table"}) and accordingly shows the strongest correlations of PEM values among oligonucleotide microarray, SAGEmap, and TissueInfo (Table [1](#T1){ref-type="table"}). Prostate, the tissue category with the second highest total number of tags, showed good correlation between SAGEmap and TissueInfo, but the correlation between the tag-based databases and oligonucleotide microarray data was weaker (*r*^2^of 0.09 and 0.19 for SAGEmap and TissueInfo respectively).

###### 

Number of SAGE and EST tags in tissue categories derived from SAGEmap and TissueInfo.

             Brain     Prostate   Kidney    Vascular endothelium   Ovary     Pancreas
  ---------- --------- ---------- --------- ---------------------- --------- ----------
  SAGE       326,481   150,116    67,923    110,460                96,911    64,577
  EST        154,214   51,299     60,188    8,435                  12,587    23,545
  SAGE+EST   480,695   201,415    128,111   118,895                109,498   88,122

We suggest that the relative complexity of a tissue is another important factor for comparison of high-throughput expression profiles deposited in public databases. Complex tissues consist of many cell types that may be mixed in different proportions in different samples. Expression profiles obtained from these tissues will be heterogeneous and consequently require a large number of tags and repeated hybridizations to detect signal in the noise. This is shown by the relatively strong correlations seen in SAGEmap/TissueInfo and SAGEmap/microarray correlations for vascular endothelium despite the small number of tags available (in comparison to brain, about 3-fold fewer SAGE tags and 18-fold fewer EST tags). SAGEmap and dbEST/TissueInfo vascular endothelium libraries are derived from *in vitro*cultures or homogenous primary isolates of vascular endothelial cells \[[@B13]\].

Correlations of PEM scores obtained from the three databases for kidney, pancreas, and ovary had very low *r*^2^values (Table [1](#T1){ref-type="table"}). However, measuring the correlation coefficient of PEM scores is a very rigorous test of congruence, because it not only requires that two datasets being compared identify the same sets of genes as being over- or under-expressed in the tissue, but also that the genes deviate from uniform expression to a similar degree. This may be an unrealistic expectation; for example, it is apparent from Figure [1](#F1){ref-type="fig"} that PEM scores for SAGEmap in brain never exceed +1.19 (i.e., approximately 15-fold over-representation), which is probably due to the limited size of the SAGE database. A simpler test is to divide the plots into quadrants and measure the fraction of genes for which the two methods being compared give PEM scores with the same sign. For example, for brain tissue the PEM scores from SAGEmap and TissueInfo data are both positive for 134 genes, both negative for 184 genes, and in disagreement for only 28 genes (i.e., one method identifies the gene as significantly over-expressed in brain, and the other identifies it as significantly under-expressed) (Figure [1](#F1){ref-type="fig"}). Across all six tissues and three datasets, the PEM signs are in agreement for more than 50% of genes (the null expectation) in 13 of the 18 comparisons made (Table [1](#T1){ref-type="table"}).

Tissue-specific genes
---------------------

We showed previously that integrating two expression databases (SAGEmap and dbEST) provided accurate predictions of vascular endothelium-specific expression that were verified experimentally, whereas neither method alone was reliable \[[@B13]\]. Similarly, genes for which Gene Expression Atlas, SAGEmap and TissueInfo analyses all yield positive PEM scores should be very strong candidates for being tissue-specific. To test this hypothesis, we integrated PEM scores from the three types of expression profile to search for putative brain-specific genes. The 50 top-scoring genes were investigated through LocusLink and OMIM and of these 47 proved to be previously known brain-specific or preferentially brain expressed genes (Table [3](#T3){ref-type="table"}). Three genes were novel, one of which was highly similar to a known brain-specific inorganic phosphate co-transporter. This confirms the very high reliability of integrated predictions of tissue-specific expression. The bottom-scoring ten genes for brain are also listed in Table [1](#T1){ref-type="table"}. They have negative PEM values indicating under-representation in the brain transcriptome. Four of these genes are epithelial markers (EPCAM, KRT5, KRT18, and KRT19).

###### 

Top 50 brain-specific and bottom ten brain underexpressed genes (*in italics*) identified by integrated PEM scores from Gene Expression Atlas, SAGEmap and TissueInfo.

  %PEM ^a^   UniGene cluster   LocusLink symbol   Description and references
  ---------- ----------------- ------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  76%        Hs.6535           n/a                novel cDNA clone, FLJ33742 fis, highly similar to Homo sapiens BNPI mRNA for brain-specific Na-dependent inorganic phosphate cotransporter (GenBank AK091061)
  76%        Hs.143535         CAMK2A             calcium/calmodulin-dependent protein kinase, implied in control of fear and aggression \[[@B18]\]
  75%        Hs.78854          ATP1B2             ATPase, Na+/K+ transporting \[[@B19],[@B20]\]
  74%        Hs.194301         MAP1A              microtubule-associated protein, expressed strongly in brain, spinal cord and weakly in muscle \[[@B21]\]
  73%        Hs.84389          SNAP25             synaptosomal associated protein; one of SNARE proteins required for neuronal exocytosis \[[@B22]\]
  72%        Hs.2288           VSNL1              visinin like 1; known to be expressed in neuronal cells in retina \[[@B23]\]
  72%        Hs.1787           PLP1               lipophilin -- the primary constituent of myelin \[[@B24]\]
  72%        Hs.296184         GNAO1              G protein alpha activating activity polypeptide O; multiple neurological abnormalities in knock-out mice \[[@B25]\]; cloned from brain \[[@B26]\]
  71%        Hs.75819          GPM6A              neuronal membrane glycoprotein M6A; similar to myelin proteolipid protein \[[@B27]\]
  71%        Hs.69547          MBP                myelin basic protein \[[@B28]\]
  70%        Hs.74565          APLP1              amyloid beta (A4) precursor-like protein 1 \[[@B29]\]
  69%        Hs.6139           SYNGR1             synaptogyrin 1 \[[@B30]\]
  69%        Hs.154679         SYT1               synaptotagmin 1 \[[@B31]\]
  68%        Hs.20912          APCL               brain-specific adenomatous polyposis coli (APC) homologue \[[@B32]\]
  66%        Hs.5422           GPM6B              neuronal membrane glycoprotein M6B, highly similar to the myelin proteolipid protein \[[@B27]\]
  66%        Hs.79000          GAP43              neuromodulin, implied in axon guidance \[[@B33]\]
  65%        Hs.22777          CA11               carbonic anhydrase XI; brain-specific carbonic anhydrase isosyme \[[@B34]\]
  65%        Hs.239356         STXB1              syntaxin binding protein 1 \[[@B35]\]
  65%        Hs.182859         LFG                lifeguard (alias neuromembrane protein 35) \[[@B36]\]
  65%        Hs.7979           SV2                synaptic vesicle glycoprotein 2 \[[@B37]\]
  64%        Hs.322430         NDRG4              ndrg family member 4, expressed in brain and heart \[[@B38]\]
  64%        Hs.74554          SYT11              synaptotagmin 11; identified by genomic screen with highly conserved synaptotagmin motif \[[@B39]\]
  64%        Hs.82749          TM4SF2             transmembrane 4 superfamily member 2; contains a trinucleotide repeat \[[@B40]\], implied in X linked mental retardation \[[@B41]\], implied in axon guidance
  64%        Hs.169401         APOE               apolipoprotein E; implied in Alzheimer\'s disease \[[@B42]\]
  63%        Hs.166161         DNM1               dynamin 1 -- brain expression at least 30-fold higher than in other tissues \[[@B43]\]
  62%        Hs.6164           NECL1              nectin-like protein 1; alias brain immunoglobulin receptor precursor (unpublished, GenBank NM_021189)
  62%        Hs.76888          INA                internexin -- neuronal intermediate filament protein alpha \[[@B44]\]
  61%        Hs.146580         ENO2               enolase 2 -- neuronal-specific enolase \[[@B45]\]
  61%        Hs.90005          STMN2              stathmin-like 2; expressed in neuronal growth cones \[[@B46]\]
  61%        Hs.226133         GAS7               growth arrest-specific 7; expressed in neurons and growth-arrested fibroblasts \[[@B47]\]
  60%        Hs.155524         PNUTL2             septin 4; human orthologue of the mouse h5 brain protein \[[@B48]\]; involved in cell-division control; expressed in brain and, an alternatively spliced form, in heart \[[@B49]\]
  60%        Hs.117546         NNAT               neuronatin; known to contain a 5\' neurospecific silencer element which controls brain-specific expression \[[@B50]\]; possible role in brain development
  60%        Hs.155247         ALDOC              brain-type aldolase; fructose-bisphosphate aldolase C \[[@B51]\]
  60%        Hs.7357           CLIPR-59           microtubule-binding protein involved in Golgi targeting; known to be preferentially expressed in brain \[[@B52]\]
  60%        Hs.74583          SPOCK2             sparc/osteonectin like; testican 2; calcium-binding proteoglycan specific to brain; expressed in many neuronal cell types in olfactory bulb, cerebral cortex, thalamus, hippocampus, cerebellum, and medulla \[[@B53]\]
  60%        Hs.80395          MAL                hydrophobic integral membrane lipoprotein; a component of myelin \[[@B54]\]
  60%        Hs.6349           BC008967           novel protein BC008967
  60%        Hs.6755           RPIP8              RaP2 interacting protein; belongs to Ras family; expressed principally in brain \[[@B55]\]
  60%        Hs.75090          SPRING             involved in synaptic exocytosis; expressed only in brain \[[@B56]\]
  60%        Hs.90063          NCALD              neurocalcin delta; calcium-binding protein; expressed preferentially in brain \[[@B57]\]
  58%        Hs.83384          S100B              calcium-binding protein S100; expressed in glia, astrocytes and neurons \[[@B58]\]
  58%        Hs.104925         ENC1               ectodermal-neural cortex; p53 induced gene; expressed preferentially in brain, particularly in amygdala and hippocampus \[[@B59]\]
  58%        Hs.7782           PNMA2              onconeuronal antigen MA2; expressed in brain and testis \[[@B60]\]
  58%        Hs.8526           B3GNT6             beta-1,3-N-acetylglucosaminyltransferase 6; expressed preferentially in foetal and adult brain \[[@B61]\]
  56%        Hs.125359         THY1               Thy-1 cell surface antigen; expressed in brain and on some T cells; neuronal expression pattern changes in development suggesting role in neurogenesis \[[@B62]\]
  56%        Hs.194534         VAMP2              synaptobrevin 2; one of proteins involved in fusion of synaptic vesicles with the presynaptic membrane \[[@B63]\]
  56%        Hs.31463          ELMO1              engulfment and cell motility 1; orthologue of C. elegans gene ced-12; has two isforms -- 4.4 kb expressed ubiquitously and 2.4 kb expressed only in brain \[[@B64]\]
  55%        Hs.3763           APBB1              amyloid beta (A4) precursor protein-binding; expressed preferentially in brain \[[@B65]\]
  55%        Hs.286055         CHN2               chimerin 2; expressed preferentially in cerebellum in granule cells \[[@B66]\]
  55%        Hs.12305          DKFZP566B183       novel protein DKFZP566B183
  *-50%*     *Hs.80988*        *COL6A3*           *collagen type VI alpha 3 chain; type 3 alpha chain of a beaded filament collagen found in most connective tissues*\[[@B67]\]
  *-50%*     *Hs.79914*        *LUM*              *lumican, a keratan sulfate proteoglycan known to be abundant in the corneal stroma and collagenous matrices of the heart, skeletal muscle, aorta, and intervertebral discs*\[[@B68]\]
  *-51%*     *Hs.38972*        *TSPAN-1*          *tetraspan 1*\[[@B69]\]
  *-53%*     *Hs.692*          *EPCAM*            *epithelial cellular adhesion molecule; expressed only on epithelial cells*\[[@B70]\]
  *-56%*     *Hs.297681*       *SERPINA1*         *antitrypsin, primarily expressed in liver*\[[@B71]\]
  *-57%*     *Hs.5372*         *CLDN4*            *claudin 4; expressed in kidney, small intestine, lung, heart, liver, and skeletal muscle; no expression was found in brain or spleen*\[[@B72]\]
  *-57%*     *Hs.81892*        *KIAA0101*         *identified in the Kazusa large-scale cDNA sequencing project*\[[@B73]\]; *northern blot revealed expression in many tissues but signal is completely absent from brain*<http://www.kazusa.or.jp/huge/gfpage/KIAA0101/>
  *-58%*     *Hs.195850*       *KRT5*             *keratin 5; expressed in many epithelia including mammary epithelial cells and squamous epithelia lining the upper digestive tract*\[[@B74]\]
  *-59%*     *Hs.65114*        *KRT18*            *keratin 18*\[[@B75]\]; *expressed in many epithelia*
  *-60%*     *Hs.182265*       *KRT19*            *keratin 19; found predominantly in the periderm -- the transient layer that surrounds the developing epidermis*\[[@B76]\]

^a^Integrated PEM score, calculated as the average of PEMGEA/PEMGEA~max~, PEMSAGEMAP/PEMSAGEMAP~max~, PEMTISSUEINFO/PEMTISSUEINFO~max~, where \"max\" refers to the maximum PEM value encountered in the tissue. This weighting scheme was used because brain microarray PEM values were several fold higher than those for SAGE and EST (PEMGEA~max~= 5.21, PEMSAGEMAP~max~= 1.19, PEMTISSUEINFO~max~= 1.15)

The top ten prostate-specific genes are listed in Table [4](#T4){ref-type="table"}. As with the analysis for brain, combining Gene Expression Atlas, SAGEmap and TissueInfo data appears to identify prostate-specific genes successfully. Five genes were previously known to be expressed specifically by prostate epithelium (MSMB, ACPP, KLK3, AMD1 and RDH11). The other five are muscle-specific genes. This is not unexpected since the fibromuscular stroma surrounding prostatic glands is known to account for about half of the volume of the prostate \[[@B14]\].

###### 

Top ten prostate-specific genes identified by integrated PEM scores from Gene Expression Atlas, SAGEmap and TissueInfo.

  %PEM ^a^   UniGene cluster   LocusLink symbol   Description and references
  ---------- ----------------- ------------------ ------------------------------------------------------------------------------------------------------------------------------------
  95%        Hs.183752         MSMB               beta microseminoprotein; synthesized by the epithelial cells of the prostate gland and secreted into the seminal plasma \[[@B77]\]
  94%        Hs.1852           ACPP               prostatic acid phosphatase \[[@B78]\]
  82%        Hs.171995         KLK3               kallikrein 3; prostate specific antigen (PSA) \[[@B79]\]
  73%        Hs.78344          MYH11              smooth muscle-specific myosin heavy polypeptide 11 \[[@B80]\]
  70%        Hs.300772         TPM2               tropomyosin 2 (beta); binds actin \[[@B81]\]
  55%        Hs.195464         FLNA               filamin A; binds actin \[[@B82]\]
  54%        Hs.75777          TAGLN              transgelin; smooth muscle-specific actin binding protein \[[@B83]\]
  53%        Hs.262476         AMD1               S-adenosylmethionine decarboxylase 1; key enzyme in the synthesis of seminal polyamines such as spermine, spermidine \[[@B84]\]
  53%        Hs.9615           MYL9               myosin, smooth muscle-specific regulatory light polypeptide 9 \[[@B85]\]
  48%        Hs.179817         RDH11              androgen-regulated short-chain dehydrogenase/reductase 1 \[[@B86]\]

^a^Prostate PEMGEA~max~= 4.30, PEMSAGEMAP~max~= 1.97, and PEMTISSUEINFO~max~= 1.61

Conclusions
===========

We show here that data from Gene Expression Atlas, SAGEmap and TissueInfo can be integrated when libraries are grouped into higher-level tissue categories and genes are mapped between datasets using the UniGene gene index. After integration, expression profiles between tissue categories represented in multiple databases can be compared using a measure of differential expression, PEM. Internal consistency of PEM scores is high for Gene Expression Atlas but poorer in the tissue categories derived from SAGEmap and TissueInfo. Between datasets, PEM values correlate relatively well when large numbers of SAGE and EST tags are available (brain, prostate) or when tissue cellular composition is simple (vascular endothelium), but in the other tissue categories examined the correlation is low. The usefulness of the integrated dataset is demonstrated by the accuracy with which brain- and prostate-specific genes could be identified. This suggests that similar accuracy could be achieved for other tissues if oligonucleotide microarray, SAGE, and EST experiments were performed on RNAs from the same well-annotated tissue samples of relatively simple cellular composition. This would also enable direct comparison and benchmarking of expression profiles obtained using different technologies. The integrated dataset, code and database schema are available on request from L.H.

Methods
=======

Gene Expression Atlas
---------------------

Affymetrix U95A oligonucleotide microarray \[[@B15]\] data for 12,587 consensus probes in 101 human tissue samples were downloaded from the Gene Expression Atlas website <http://expression.gnf.org/data_public_U95.gz>. Image analysis and normalization has been performed using Genechip 3.2 software (Affymetrix, Santa Clara, CA) by Su et al. \[[@B11]\]. The libraries were grouped into 47 higher-level tissue categories (averaging across duplicates and triplicates). Tumour libraries were grouped as separate to normal tissues and not used for further analysis.

SAGEmap
-------

Tag frequencies for 132 SAGEmap libraries \[[@B1]\] were obtained from the project ftp site <ftp://ftp.ncbi.nih.gov/pub/sage>. After downloading, the libraries were grouped into 15 higher-level tissue categories (brain, prostate, kidney, colon, pancreas, ovary, breast, skin, peritoneum, stomach, blood, lung, liver, heart and vascular endothelium) and annotated according to their disease status (91 tumour tissues, 37 normal tissue libraries and four immortalised cell lines). Unless stated otherwise, only normal tissue libraries (total of 1,077,231 tags) were used for further analysis.

TissueInfo
----------

The TissueInfo \[[@B12]\] database links ESTs from dbEST to the tissue where there are expressed by assigning a tissue-key to each EST entry. The dataset was downloaded from the TissueInfo website <http://icb.mssm.edu/tissueinfo/local-inst.xml>, which is updated daily, on 27 February 2002. Our aim was to group EST into major tissues with sufficient numbers of ESTs for statistically meaningful analysis. Therefore, some TissueInfo categories were grouped together into higher-level tissue categories. For example hypothalamus was also annotated as brain. We excluded ESTs that were annotated as mitochondrial libraries, tumour libraries, or multiple tissues. This procedure resulted in 48 higher-level tissue categories, 27 of which had EST counts in excess of 10,000 (the number of ESTs we accepted as the threshold for dataset size). We also included vascular endothelium (8,435 ESTs) because of the high number of SAGE tags available for this category (110,460) and its simple cellular composition.

Mapping
-------

Six higher-level tissue categories were available for comparison between Gene Expression Atlas, SAGEmap, and TissueInfo (Table [1](#T1){ref-type="table"}). An integrated MySQL database was set up and gene identifiers from the UniGene gene index were used to link expression data from the three datasets. Only UniGene entries with more than one EST (62,008 entries) were considered as valid clusters. UniGene mapping was provided as part of both SAGEmap and TissueInfo datasets. To map oligonucleotide microarray probes, probe consensus sequences were searched against longest representative sequence of each UniGene cluster using BLASTN with the cutoff parameter E = 10e-20. Alignments were accepted if the percentage identity was higher than 94% and length was at least 99 bp or 90% of the length of the query, or when percentage identity was 100% and length more than 49 bp \[[@B11]\].

When linking UniGene clusters to SAGEmap data, UniGenes mapping to more than SAGE tag sequence were excluded (25% of clusters). The size of the Unigene dataset linked to SAGEmap was, therefore, reduced from 21,224 to 15,872 clusters. Similarly, Unigene clusters mapping to more than one Affymetrix probe were excluded (22% of clusters). The size of the Unigene dataset linked to Gene Expression Atlas data was, therefore, reduced from 9,402 to 7,375 clusters. The overlaps between UniGenes linked to GEA and SAGEmap, GEA and TissueInfo, and SAGEmap and TissueInfo were 2742, 6758 and 15872 clusters respectively. Therefore:

\- 63% and 8% of UniGene clusters linked to GEA could not be linked to SAGEmap and TissueInfo respectively;

\- 83% and 0% of UniGene clusters linked to SAGEmap could not be linked to GEA and TissueInfo respectively;

\- 74% and 89% of UniGene clusters linked to TissueInfo could not be linked to SAGEmap and GEA respectively.

Statistics
----------

Gene expression can be estimated by counting gene-specific SAGE and EST tags but, as a stochastic process, these estimates are subject to sampling error. The size of the sampled dataset can have a dramatic influence on reliability of the data. Two independent groups have established χ^2^as the best statistical test to use in tag sampling experiments \[[@B16],[@B17]\]. We excluded from subsequent comparative analysis all tissue/gene data for which the expected number of tags (*e*) was less than 5, which is the lower limit of reliability for the χ^2^statistic. We used χ^2^to filter the PEM score for both tag-based methods: unless significantly different from expectation (with *P*= 0.05) we concluded that we had no confidence in either the sign or the magnitude of the apparent deviation from uniform expression. A relatively low significance threshold of 0.05 was used to maximize the number of values available for inter-database comparison. Because χ^2^test is only used on a case-by-case basis for preliminary selection of informative datapoints, a multiple testing correction such as Bonferroni correction was not applicable.

To compare the results from any two databases for a given tissue, we plotted the PEM scores for all genes for which data was available from the two experiments, but excluding SAGE and EST data with non-significant χ^2^. We calculated the correlation coefficient (*r*) and report *r*^2^, which represents the proportion of the variability in the data that is explained by the correlation.

Database versions
=================

Gene Expression Atlas, Affymetrix human Genechip U95A <http://expression.gnf.org>

SAGEmap, January 2002 <http://www.ncbi.nlm.nih.gov/SAGE/>

TissueInfo, 27 February 2002 <http://icb.mssm.edu/crt/tissueinfowebservice.xml>

UniGene, Build 148 <http://www.ncbi.nlm.nih.gov/UniGene/>
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